Explore petrochemical downturn impacts, margin and cash flow pressure, China-led overcapacity, and who’s best set for a rebound—read now.
Good morning, and welcome to DNO's Full Year 2025 Interim Results Earnings Call. My name is Jostein Lovas, and I am the ...
Novo Nordisk is fighting back with CagriSema, a powerful combination therapy that demonstrated 22.7% weight loss in its own Phase 3 trials. While this result is superior to the current market leader, ...
The first week of February 2026 will be remembered as the day the pharmaceutical sector’s most famous partnership officially dissolved. For years, Eli Lilly and Company (NYSE: LLY) and Novo ...
Since the establishment of Nigerian Content Development and Monitoring Board (NCDMB) in 2010, it has been series of ...
Thanks, Guy, and thank you to everyone for joining our fourth quarter 2025 earnings conference call. 2025 was another very ...
We have a really strong backlog for the current quarter, and the bookings have been quite high. So the backlog is continuing ...
The early 2000s were a good time to be a sport truck fan. After sporadic entrants to the market from American truck brands, ...